On the recordSeptember 30, 2020
This committee's investigation shines a spotlight on the ways that drug companies use litigation as a key part of their strategic plans to delay generic entry.
Source
congress.govThis committee's investigation shines a spotlight on the ways that drug companies use litigation as a key part of their strategic plans to delay generic entry.
Wasserman Schultz discusses drug companies' tactics to maintain high prices through litigation.
Share
More from Debbie Wasserman Schultz
Our campaign galvanized an unstoppable coalition of energized congregations, unions, LGBTQ+ advocates and proud Black, Caribbean and Hispanic communities, and we did it in the face of a rushed, brazenly illegal Republican gerrymander.
Making life more affordable. I mean, whether it's gas, groceries, utilities, housing, healthcare.
That’s why I’m running: to deliver resources to the people of Broward who know and trust me and want me to keep fighting for them.